Micron signs research agreement with leading biotech company

ATLANTA, March 2, 2017 – Micron Biomedical, Inc. and an Asia-based biotechnology company enter into a research collaboration to evaluate Micron’s technology for administration of the company’s ground-breaking therapeutics platform technology that can be applied to treat a variety of diseases. The terms of the collaboration are confidential.